Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ute Marx"'
Autor:
Hugues Chabriat, Claudio L. Bassetti, Ute Marx, Françoise Picarel-Blanchot, Aurore Sors, Celine Gruget, Barbara Saba, Marine Wattez, Marie-Laure Audoli, Dirk M. Hermann
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background The GABAA-α5 receptor antagonist S44819 is a promising candidate to enhance functional recovery after acute ischemic stroke (IS). S44819 is currently evaluated in this indication; RESTORE brain study started in Dec 2016 and was c
Externí odkaz:
https://doaj.org/article/d4fef49d73f649789a8ca02b12e09ddc
Publikováno v:
EPIC3Environmental Science & Technology, 55(22), pp. 15495-15504, ISSN: 0013-936X
Dissolved organic matter (DOM) is an important component in marine and freshwater environments and plays a fundamental role in global biogeochemical cycles. In the past, optical and molecular-level analytical techniques evolved and improved our mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f5559193ef0776683d4b4c57136939
https://doi.org/10.5194/egusphere-egu22-9757
https://doi.org/10.5194/egusphere-egu22-9757
Autor:
Celso Arango, Jan K Buitelaar, Jörg M Fegert, Valérie Olivier, Pierre-François Pénélaud, Ute Marx, Damien Chimits, Bruno Falissard, Julia Barylnik, Laura Birdeanu, Gert P Bosch, Julia Boychevskaya, Igor Boyev, Enikõ Bugán, Olga Bukhanovskaya, Oleg Chaban, Iuliana Dobrescu, Gábor Feller, Halina Flisiak-Antonijczuk, Magdolna Gácser, Elena Grigorieva, Timo Holttinen, Svetlana Ivanovic-Kovacevic, Krisztina Kapornai, Lala Kasimova, Evgeniy Koren, Igor Martsenkovsky, Nataliya O Maruta, Mirela Matican, Tetiana Matkovska, Ellina Melnyk, Milica Pejovic Milovancevic, Olha Mostova, Peter Nagy, Laura Nussbaum, Petar Petrov, Bozena Pietraszczyk-Kedziora, Nadia Polnareva, Elena Predescu, Vladislava Razsolkova, Filip Rybakowski, Sofiia Rymsha, Juan P Schrönen, Dmitrii Shigashov, Andrii Skrypnikov, Miodrag Stankovic, Dejan Stevanovic, Markku Timonen, Juha-Matti Väänänen, Jannie van der Westhuizen, Gert van Niekerk, Olena Venger, Anatolii Voloshchuk, Tomasz Wolañczyk
Publikováno v:
The Lancet Psychiatry, 9, 113-124
The Lancet Psychiatry, 9, 2, pp. 113-124
The Lancet Psychiatry, 9, 2, pp. 113-124
Major depressive disorder is a severe illness that frequently manifests before the age of 18 years, often recurring later in life. Paediatric medical treatment options are scarce. The melatonin receptor agonist and 5-hydroxytryptamineWe performed a 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e63896409003e7448dbb4b94aac198
http://hdl.handle.net/2066/247758
http://hdl.handle.net/2066/247758
Autor:
Peter D. Schellinger, Agnes Koves, Usman A. Khan, Didier Smadja, Gabriel Rodriguez Freitas, Ralf Lindert, Bill O'brien, Jaime Masjuan Vallejo, Aida Lago Martin, Cesar Minelli, Hassan Hosseini, Marine Wattez, Martin Grond, Claudio L. Bassetti, Konrad Rejdak, Marie-Laure Audoli-Inthavong, Luisa Rover, Pere Cardona, Kenneth Butcher, Gabriel R. de Freitas, Gyula Panczel, Tomas Segura Martin, Marianna Gottschal, Maurício André Gheller Friedrich, Hugues Chabriat, Alvaro Ximenez Carrillo, Laura Dorado, Jean-Philippe Neau, Joerg Berrouschot, D. G. Nabavi, Carla H.C. Moro, Nina De Klippel, Norbert Szegedi, Tomasz Berkowicz, Jesse Dawson, Andras Folyovich, Christian Denier, Jean-Louis Mas, Klaus Gröschel, Amit K Mistri, Thanh G. Phan, Timothy Kleinig, Aurore Sors, Dirk M. Hermann, Louise Shaw, Christine Roffe, Nikola Sprigg, Man Seok Park, Hans-Christoph Diener, Hassan Soda, Maite Martinez Zabaleta, Pietro Bassi, Luiz Carlos Porcello Marrone, Dylan Blacquiere, László Vécsei, Stephen N. Davis, Giuseppe Lembo, Rohan Grimley, Charlotte Cordonnier, Geert Vanhooren, Bernd Kallmuenzer, Peter Dioszeghy, Mikael Mazighi, Waldemar Brola, Francisco Moniche Alvarez, Yangha Hwang, Attila Valikovics, Waldemar Fryze, Philippe Desfontaines, Jaume Roquer Gonzalez, David Cohen, Zbigniew Bak, Csaba Ovary, Jae-Kwan Cha, Gisele Sampaio Silva, Carlos A. Molina, Rodrigo Bazan, Hee-Joon Bae, Rubens José Gagliardi, Geoffrey Cloud, Anna Członkowska, Attila Csanyi, Leonardo Barbarini, Sergi Amaro, Jong Sung Kim, Daniel Bereczki, Katharina Althaus, Robin Lemmens, Anetta Lasek-Bal, Theodore Wein, Piotr Sobolewski, Diederik Willem Dippel, Danilo Toni, Laszlo Szapary, Suzanne Ragab, Andrew Wong, Ute Marx, Estelle Lambert, Igor Sibon, Wim M. Mulleners, Ondrej Skoda, Maciej Swiat
Summary Background S44819, a selective GABAA α5 receptor antagonist, reduces tonic post-ischaemic inhibition of the peri-infarct cortex. S44819 improved stroke recovery in rodents and increased cortical excitability in a transcranial magnetic stimul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b691f063532bca5bfdd45c9b4f2ad883
https://iris.uniroma1.it/handle/11573/1474965
https://iris.uniroma1.it/handle/11573/1474965
Autor:
Aurore Sors, Ute Marx, Claudio L. Bassetti, Hugues Chabriat, F. Picarel-Blanchot, Dirk M. Hermann, Marine Wattez, Marie-Laure Audoli, Barbara Saba, Celine Gruget
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Chabriat, Hugues; Bassetti, Claudio L.; Marx, Ute; Picarel-Blanchot, Françoise; Sors, Aurore; Gruget, Celine; Saba, Barbara; Wattez, Marine; Audoli, Marie-Laure; Hermann, Dirk M. (2020). Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study. Trials, 21(1), p. 136. BioMed Central 10.1186/s13063-020-4072-2
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Chabriat, Hugues; Bassetti, Claudio L.; Marx, Ute; Picarel-Blanchot, Françoise; Sors, Aurore; Gruget, Celine; Saba, Barbara; Wattez, Marine; Audoli, Marie-Laure; Hermann, Dirk M. (2020). Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study. Trials, 21(1), p. 136. BioMed Central 10.1186/s13063-020-4072-2
Background The GABAA-α5 receptor antagonist S44819 is a promising candidate to enhance functional recovery after acute ischemic stroke (IS). S44819 is currently evaluated in this indication; RESTORE brain study started in Dec 2016 and was completed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeeab23d617412ae568ee9f511cc7cb1
Autor:
Dirk M. Hermann, Claudio L. Bassetti, Ute Marx, Marie-Laure Audoli-Inthavong, Hugues Chabriat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb28dbc05bdb664075de2213d8cbaa4
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85083451535
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85083451535
Autor:
Hugues, Chabriat, Claudio L, Bassetti, Ute, Marx, Marie-Laure, Audoli-Inthavong, Aurore, Sors, Estelle, Lambert, Marine, Wattez, Dirk M, Hermann, Alvaro, Ximenez Carrillo
Publikováno v:
The Lancet. Neurology. 19(3)
S44819, a selective GABARESTORE BRAIN was an international, randomised, double-blind, parallel-group, placebo-controlled, multicentre phase 2 trial that evaluated the safety and efficacy of oral S44189 in patients with recent ischaemic stroke. The st
Publikováno v:
Marine Environmental Research. 66:12-14
Every day new extraordinary properties of nanoparticles (a billionth of a meter) are discovered and worldwide millions are invested into nanotechnology and nanomaterials. Risks to marine organisms are still not fully understood and biomarkers to dete
Publikováno v:
Journal of the Chemical Society, Faraday Transactions 1: Physical Chemistry in Condensed Phases. 82:2505
The adsorption of n-octadecylamine on α-Fe2O3 at the solid/liquid interface, and of n-butylamine at the solid/liquid and solid/vapour interfaces has been studied by infrared spectroscopy. To obtain further information about the nature of desorbing p